Jyothy Labs Limited (JYOTHYLAB) AI Stock Analysis

• Market Cap: ₹114.09B
• Dividend Yield: 1.12%
• Average Volume (3M): 27.81K
• Price to Earnings (P/E): 31.2
• Beta (1Y): 0.79
• Revenue Growth: 1.59%
• EPS Growth: -2.52%
• Country: IN
• Employees: 2,943
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 2.60
• Shares Outstanding: 367,214,500
• 10 Day Avg. Volume: 28,113
• 30 Day Avg. Volume: 27,812
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹402.75
• Price Target Upside: 29.63% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 68 Neutral
• Price Target: ₹367.00 ▲(18.12% Upside)

Jyothy Labs Limited's overall stock score is driven primarily by its strong financial performance, which is a key strength. However, the technical analysis indicates mixed signals, and the valuation suggests potential overvaluation, which tempers the overall score. The absence of earnings call data and notable corporate events means these factors do not influence the score.

Jyothy Labs Limited Business Overview & Revenue Model

Company Description

Jyothy Labs Limited is an Indian multinational consumer goods company that operates in the fast-moving consumer goods (FMCG) sector. It was founded in 1983 and is headquartered in Mumbai, India. The company is engaged in the manufacturing and marketing of a wide range of products across categories like fabric care, dishwashing, household insecticides, personal care, and others. Some of its well-known brands include Ujala, Maxo, Exo, and Henko.

How the Company Makes Money

Jyothy Labs Limited generates revenue primarily through the sale of its diverse range of consumer goods in the FMCG sector. The company earns money by manufacturing and selling products across various categories such as fabric care, dishwashing, household insecticides, and personal care. Key revenue streams include sales from popular brands like Ujala for fabric whitening agents, Maxo for mosquito repellents, Exo for dishwashing solutions, and Henko for premium detergents. The company has a strong distribution network across India, which aids in reaching a vast customer base. Additionally, Jyothy Labs engages in marketing and promotional activities to enhance brand visibility and drive sales. While the company has some international presence, its primary market remains India. Strategic partnerships and collaborations with distributors and retailers also play a significant role in its revenue generation.

Jyothy Labs Limited Financial Statement Overview

Summary

Jyothy Labs Limited exhibits strong financial performance with consistent revenue and profit growth, effective cost management, and solid cash flow generation. The balance sheet is robust with low leverage, although a high equity ratio could limit financial flexibility. The company should focus on maintaining cash flow efficiency to sustain growth momentum.

Income Statement

Jyothy Labs Limited shows strong revenue growth with a consistent increase from INR 17,097 million in 2020 to INR 28,469 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management and pricing strategies. Net profit margin has also remained stable, contributing to overall profitability. The EBIT and EBITDA margins reflect robust operational efficiency. However, attention is needed on the slight volatility in EBIT margins over the years.

Balance Sheet

The company maintains a solid balance sheet with a favorable debt-to-equity ratio, decreasing from 0.27 in 2020 to 0.03 in 2025, showcasing effective debt management and strong equity base. The return on equity is commendable, enhancing investor confidence. However, the equity ratio suggests a high reliance on equity financing, which could limit leverage benefits.

Cash Flow

Jyothy Labs has demonstrated strong cash flow generation with positive free cash flow growth. The operating cash flow to net income ratio indicates efficient conversion of income into cash, although there was a decline in operating cash flow in recent years. The company's free cash flow to net income ratio is solid, reflecting effective capital expenditure management. However, the decline in operating cash flow from 2024 to 2025 suggests potential challenges in cash generation operations.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2021	Dec 2021
Income Statement
Total Revenue	28.47B	28.47B	24.86B	27.55B	19.08B	21.95B
Gross Profit	13.28B	14.27B	10.51B	10.01B	8.89B	9.03B
EBITDA	5.33B	4.74B	3.62B	5.34B	3.09B	2.67B
Net Income	3.70B	3.70B	2.40B	3.69B	1.99B	1.62B
Balance Sheet
Total Assets	26.91B	26.91B	20.62B	24.01B	19.56B	20.23B
Cash, Cash Equivalents and Short-Term Investments	5.99B	5.99B	2.86B	6.16B	1.87B	2.04B
Total Debt	612.80M	612.80M	465.30M	505.60M	1.67B	1.71B
Total Liabilities	6.41B	6.41B	5.11B	5.91B	5.65B	6.20B
Stockholders Equity	20.50B	20.50B	15.49B	18.08B	14.29B	14.44B
Cash Flow
Free Cash Flow	0.00	2.53B	2.93B	4.21B	3.76B	1.77B
Operating Cash Flow	0.00	3.11B	3.29B	4.58B	4.02B	2.03B
Investing Cash Flow	0.00	-1.61B	-482.90M	-3.44B	-1.29B	-317.13M
Financing Cash Flow	0.00	-1.57B	-2.51B	-1.35B	-2.16B	-1.67B

Jyothy Labs Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 310.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Negative. The current price of 310.7 is below the 20-day moving average (MA) of 326.20, below the 50-day MA of 330.34, and below the 200-day MA of 350.46, indicating a bearish trend. The MACD of -4.50 indicates Positive momentum. The RSI at 22.49 is Positive, neither overbought nor oversold. The STOCH value of 8.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JYOTHYLAB.

Jyothy Labs Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CCL	74 Outperform	₹118.45B	38.01	15.78%	0.56%	22.22%	19.04%
GALAXYSURF	74 Outperform	₹77.23B	25.35	12.91%	1.01%	18.32%	-0.43%
ZYDUSWELL	73 Outperform	₹153.21B	46.84	6.12%	0.25%	10.63%	7.53%
JYOTHYLAB	68 Neutral	₹114.09B	31.22	―	1.12%	1.59%	-2.52%
BECTORFOOD	60 Neutral	₹78.60B	56.11	12.29%	0.47%	12.92%	-4.82%
HONASA	50 Neutral	₹92.63B	125.51	6.16%	―	4.91%	-55.92%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%